FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/067720 [Registered on: 21/05/2024] Trial Registered Prospectively
Last Modified On: 20/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Unani 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Efficacy of mako,marznjosh,baboona,qaisoom in vaginal discharge  
Scientific Title of Study   Efficacy of Unani formulation (Mako, Marzanjosh, Baboona, Qaisoom) in Vaginal Discharge Syndrome: A placebo controlled double blind study.  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Hina Meraj 
Designation  PG Scholar 
Affiliation  Ajmal Khan Tibbiya College and Hospital Aligarh Muslim University Aligarh 
Address  Department of Niswan wa Qabalat Ajmal Khan Tibbiya College and Hospital Aligarh Muslim University Aligarh 202002

Aligarh
UTTAR PRADESH
202002
India 
Phone  8126398588  
Fax    
Email  mhina6217@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Abiha Ahmad Khan 
Designation  Assistant Professor 
Affiliation  Ajmal Khan Tibbiya College and Hospital Aligarh Muslim University Aligarh 
Address  Department of Niswan wa Qabalat Ajmal Khan Tibbiya College and Hospital Aligarh Muslim University Aligarh 202002

Aligarh
UTTAR PRADESH
202002
India 
Phone  9620551870  
Fax    
Email  abihaahmad89@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Hina Meraj 
Designation  PG Scholar 
Affiliation  Ajmal Khan Tibbiya College and Hospital Aligarh Muslim University Aligarh 
Address  Department of Niswan wa Qabalat Ajmal Khan Tibbiya College and Hospital Aligarh Muslim University Aligarh 202002

Aligarh
UTTAR PRADESH
202002
India 
Phone  8126398588  
Fax    
Email  mhina6217@gmail.com  
 
Source of Monetary or Material Support  
Department of Niswan wa Qabalat Ajmal Khan Tibbiya College Faculty of Unani Medicine Aligarh Muslim University India UP Aligarh 202002 
 
Primary Sponsor  
Name  Department of Niswan wa Qabalat Ajmal Khan Tibbiya College and Hospital 
Address  Ajmal Khan Tibbiya College Faculty of Unani Medicine Aligarh Muslim University Aligarh 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Hina Meraj  Ajmal Khan Tibbiya College and Hospital AMU  Department of Niswan wa Qabalat Faculty of Unani Medicine Ajmal Khan Tibbiya College and Hospital Aligarh Muslim University Aligarh
Aligarh
UTTAR PRADESH 
8126398588

mhina6217@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N760||Acute vaginitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Vaginal wash with distilled water   Vaginal wash with distilled water used locally as a perineal wash for a period of 1 month The treatment will be initiated after her menstrual period from 6th day of her cycle and continued till the 6th day of her next cycle 
Intervention  Vaginal wash with Hydroalcoholic extract of the test drug Solanum nigrum, Origanum majorana, Achillea fragmantissima, Matricaria chamomila (mako, marzanjosh, qaisoom, baboona)  Vaginal wash with Hydroalcoholic extract of the test drug Solanum nigrum, Origanum majorana, Achillea fragmantissima, Matricaria chamomila (mako, marzanjosh, qaisoom, baboona)locally as perineal wash for a period of 1month The treatment will be initiated after her menstrual period from 6th day of her cycle and continued till the 6th day of her next cycle 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  49.00 Year(s)
Gender  Female 
Details  Married females in the reproductive age group (18 to 49 years)
Subjects presenting with white discharge Per vaginum
Subjects presenting with chronic cervicitis and erosion 
 
ExclusionCriteria 
Details  Pregnant females
Patient presenting with discharge due to sexually transmitted infections and pelvic inflammatory disease
Patient with systemic diseases like Diabetes mellitus Malignancy etc
 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Double Blind Double Dummy 
Primary Outcome  
Outcome  TimePoints 
Change in vaginal pH  After every 15 days during trial to record vaginal pH drug compliance and any adverse effects.
Once post-trial after menstruation
 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in vulvo vaginal symptoms like discharge
Improvement in Quality of life
 
After every 15 days during trial to record vaginal pH drug compliance and any adverse effects.
Once post-trial after menstruation
 
 
Target Sample Size   Total Sample Size="200"
Sample Size from India="200" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   31/05/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Vaginal discharge is common and often seen in patients attending gynaecology clinics. Women normally have some vaginal discharge, which may be more pronounced during certain phases of the menstrual cycle, during and after sexual activity, and during pregnancy and lactation. In general, women only seek care for vaginal discharge if they perceive it as unusual, or if it causes itching or discomfort. In the vaginal discharge syndrome, symptoms are abnormal vaginal discharge, vaginal itching, painful urination and pain during sexual intercourse. Based on etiology it is categorized as infectious and non-infectious vaginal discharge.

 Abnormal/ Infectious vaginal discharge is defined as discharge that is different from usual with respect to colour/ odour/consistency (discoloured or purulent or malodorous).  It is often associated with vulvar pruritus or pain with intercourse (dyspareunia), or painful or difficult urination (dysuria) or lower abdominal pain. Often, vaginal discharge indicates vaginitis due to trichomoniasis, STIs (Sexually Transmitting Infections), or two naturally occurring infections; bacterial vaginosis and candidiasis. The prevalence of the infections causing vaginitis is high in many areas. These infections generally do not lead to major complications and can be easily treated. However, the lower genital tract infections are sometimes difficult to diagnose and manage as they carry a polymicrobial etiology. Cervicitis though less common may sometimes cause vaginal discharge. If left untreated, the infections causing cervicitis can lead to major complications, such as pelvic inflammatory disease.

Unani classical manuscripts elucidate the concept of vaginal discharge. It is mentioned as leucorrhoea (Sailan ul-Mani), an excessive flow of normal discharge from the uterus and vaginal discharge (Sailan ur-Rehm) as an infected discharge pouring out from the uterus. Physiologically, vaginal discharge is also noted at the time of sexual arousal; however, if the discharge is seen without sexual arousal, then the cause of the discharge is the weakness of the uterine digestive faculty (Du’fe Quwwat-i-Hadima al-Rehm). The various aetiological factors of abnormal vaginal discharge are attributed to the dominance of humour (Ghalaba-i-Akhlat) The imbalance in the four humors leads to abnormal vaginal discharge, reproductive tract infections like metritis (Waram e-rehm) and vaginitis (Waram al-Mahbil). This can also lead to the development of certain dreadful diseases, like syphilis (Aatshak), gonorrhea, and so on. It has also been mentioned in the texts that kasrate aurame rehm (uterine inflammations) and presence of morbid material within the uterine vessels causes sailan ur rehm. The discharge may also occur due to the weakness of Quwwate jazeba.  It has further been mentioned that sometimes the waste matter (fudlaat) of the body is diverted towards the uterus in order to eliminate them by natural means (istefragh). Unani scholars have used swab color assessment to diagnose the dominance of Humor (galbae khilt). The swab may turn white, yellow, red, or black when kept in the vagina overnight indicating the dominance of abnormal humor. 

The unani physicians have also classified sailan ur rehm into four types based on their pathophysiology; Sailan-ur -rehm Damwi, Sailan-ur-rehm-Safrawi, Sailan-ur- rehm Balghami, Sailan-ur-rehm Sawdavi. The management of sailan-ur-rehm depends on the diagnosis of Galba-e -Khilt and hence Ilaj bil Zid is applied. A number of Unani drugs (single as well as compound formulations) have been mentioned in the classical texts for the management such as moocharas (Bombax malabaricum), mazu (Quercus infectoria), baboona (Matricaria chamomilla) gile makhtoom (Sealing clay)gile Armani (Armenian bole), gul naar (Punica granatum), tukhme khatmi (Althea officinalis), muqil (Commiphora mukul), shibe yaman (Potassium aluminium sulphate), habul aas (Myrtus communis) etc.  Compound formulations like Marhame dakhilyoon have been in extensive use for the same.

Out of all the available Unani drugs (single as well as compound), a pharmacopeial formulation comprising of gule baboona (Matricaria chamomila), mako (Solanum nigrum), marzanjosh (Origanum majorana) and qaisoom (Achillea fragantissima) have been chosen to test for the research study. 

The importance of vaginal pH and vaginal flora in maintaining a well-balanced vaginal ecosystem is well known (SOPHY Project Vol. 60 2008) Women experience various symptoms of vaginal discharge syndrome throughout their reproductive life which can have a significant impact on their quality of life. Frequent times, the vaginal discharge is non-infectious, due to excessive perspiration, epilation of pubic hair via creams or razors, urinary or faecal incontinence and poor intimate hygiene etc. The discharge could also be due to cervical ectropion and in cases of chronic cervicitis.  In response to the symptom, women use a variety of intimate hygiene products available as Over the Counter (OTC) as part of their daily cleansing routine. Further, RCOG (Royal College of Obstetricians and Gynecologists) and MECA (Middle East and Central Asia) have suggested in their guidelines use of daily vulva cleansing with a gentle hypoallergenic liquid wash. However, the over-the-counter intimate hygiene products lack ample research on their safety on the vaginal mucosal biome and efficacy for the management of non-infectious causes of vaginal discharge.

In the unani system of medicine, extensive use of local therapy viz; use of douches, local perineal washes, pessary and suppository treatments are mentioned for vaginal discharge. For the same various number of single and compound drugs are available which have Muhallile auram (anti-inflammatory), Dafae taffun (antiseptic), Habis wa Qabiz (Astringents) properties. These drugs will alter the disturbed humoral milieu locally and therefore improve the vaginal health of the female. The drugs which are mentioned for the use in vaginal discharge syndrome include mocharas (Bombax malabaricum), mazoo (Quercus infectoria),  baboona (Matricaria chamomilla), gile makhtoom (Sealing clay)gile armani (Armenian bole), gul naar (Punica granatum), tukhme khatmi (Althea officinalis), muqil (Commiphora mukul), shibe yamani (Potassium aluminium sulphate), habul aas (Myrtus communis), kundru (Boswellia serrata) etc. Compound formulations like safoofe sailan, majoon mocharas, majoon muqawwie reham etc are being used extensively for the management of sailanur reham. Apart from these various ointments are also used locally to manage abnormal vaginal discharge viz marhame dakhilyoon. After thorough literature review the test drug gule baboona (Matricaria chamomila), mako (Solanum Nigrum), marzanjosh (Origanum majorana) and qaisoom (Achillea fragantissima) have been chosen for the research study.

We hypothesize that the local use of the test drug (vaginal wash) may be useful in regulation of vaginal health by balancing the altered humoral milieu, as well as lower the vaginal pH. Based on this, the present randomized placebo-controlled trial is aimed to assess the efficacy of Unani formulation in non-infectious vaginal discharge in reproductive aged females.

 
Close